Study shows that SNX4-mediated regulation of the steady-state levels and trafficking of BACE1, as well as the subsequent increase in BACE1-mediated cleavage, may be relevant to AD progression (Kim et al., 2017). Here, SNX4 is linked to Alzheimer disease.